Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsNiketa C Shah, MD
Associate Professor AdjunctDownloadHi-Res Photo
About
Copy Link
Titles
Associate Professor Adjunct
Director,Pediatric Cellular Therapy Program, Pediatric Hematology & Oncology; Director, Pediatric Bone Marrow Transplant Program
Appointments
Pediatric Hematology & Oncology
Associate Professor AdjunctPrimary
Other Departments & Organizations
- Pediatric Bone Marrow Transplant Program
- Pediatric Hematology & Oncology
- Pediatric Hematology & Oncology Program
- Pediatrics
- Yale Cancer Center
Education & Training
- Pediatric Stem Cell Transplant Fellow
- Memorial Sloan Kettering Cancer Center (2010)
- Pediatric Resident
- Newark Beth Israel Medical Center (2009)
- Pediatric Hematology Oncology Fellow
- The Hospital For Sick Children, Toronto (2006)
- MD
- Seth K M School of Postgraduate Medicine and Research, Pediatrics (1997)
- MBBS
- NHL Municipal Medical College (1994)
Research
Copy Link
Overview
Medical Research Interests
Anemia, Sickle Cell; Bone Marrow Failure Disorders; Bone Marrow Transplantation; Hematology; Hematopoietic Stem Cell Transplantation; Pediatrics; Receptors, Chimeric Antigen
ORCID
0000-0001-9992-4921
Research at a Glance
Yale Co-Authors
Frequent collaborators of Niketa C Shah's published research.
Publications Timeline
A big-picture view of Niketa C Shah's research output by year.
Research Interests
Research topics Niketa C Shah is interested in exploring.
Lakshmanan Krishnamurti, MD
Aron Flagg, MD
Jingchen Liang
Yanhong Deng
Daniel Prior, MD
Farzana Pashankar, MD, MRCP, MBBS
32Publications
289Citations
Hematopoietic Stem Cell Transplantation
Anemia, Sickle Cell
Bone Marrow Transplantation
Receptors, Chimeric Antigen
Publications
2026
Factors associated with pre-donation health-related quality-of-life among pediatric sibling hematopoietic cell donors; A DonorKids QL study
Switzer G, Bruce J, Shaw B, Kuniyil V, Varni J, Butler B, Erickson C, Mussetter A, Neutzling A, Abdel-Azim H, Aguayo-Hiraldo P, Anderson E, Aquino V, Boone K, Boulad F, Chewning J, Cooper J, Dahlberg A, Dvorak C, Galvez-Silva J, Haight A, Hoag J, Hudspeth M, Jacobsohn D, Kasow K, Kitko C, Krishnamurti L, Madden L, Miller H, Morales E, Olson T, Pawlowska A, Prasad V, Quigg T, Scaradavou A, Shah N, Shenoy S, Terwilliger N, Wiener L, Yanik G, Yu L, Pulsipher M. Factors associated with pre-donation health-related quality-of-life among pediatric sibling hematopoietic cell donors; A DonorKids QL study. Transplantation And Cellular Therapy 2026 PMID: 41997298, DOI: 10.1016/j.jtct.2026.04.012.Peer-Reviewed Original ResearchAltmetricRisk Factors for the Development of Avascular Necrosis Following Hematopoietic Cell Transplantation for Sickle Cell Disease
Hamidi R, Nallagatla V, Liang J, Deng Y, Flagg A, Shah N, Prior D, Krishnamurti L. Risk Factors for the Development of Avascular Necrosis Following Hematopoietic Cell Transplantation for Sickle Cell Disease. Transplantation And Cellular Therapy 2026, 32: 664.e1-664.e3. PMID: 41905705, DOI: 10.1016/j.jtct.2025.12.1002.Peer-Reviewed Original ResearchAltmetricLong-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease
Guilcher G, Dalal S, Suresh T, Yelamali A, Arora J, Aljayyousi H, Bhatia M, Haight A, Khandelwal P, Khoury R, Lafay Q, Mandava M, Nickel R, Ngwube A, Rangarajan H, Shah N, Stenger E, Yelamanchili N, Shenoy S. Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease. Transplantation And Cellular Therapy 2026, 32: 709.e1-709.e10. PMID: 41690551, DOI: 10.1016/j.jtct.2026.02.012.Peer-Reviewed Original ResearchCitations
2025
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy
Shah N, Ngwube A, Suresh T, Sowa A, Abraham A, Anderson E, Andreansky M, Bhatia M, Chaudhury S, Cuvelier G, Dalal J, Grimley M, Jacobsohn D, Kamani N, Krajewski J, Krishnamurti L, Saini S, Skiles J, Shenoy S. Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplantation And Cellular Therapy 2025, 31: 826.e1-826.e10. PMID: 40543708, DOI: 10.1016/j.jtct.2025.06.015.Peer-Reviewed Original ResearchCitationsAltmetricComparison of Regimens Used for Allogeneic Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease
Prior D, Liang J, Deng Y, Shah N, Flagg A, Krishnamurti L. Comparison of Regimens Used for Allogeneic Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease. Transplantation And Cellular Therapy 2025, 31: 594.e1-594.e13. PMID: 40379050, DOI: 10.1016/j.jtct.2025.05.004.Peer-Reviewed Original ResearchCitationsAltmetric
2024
Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease
Krishnamurti L, Liang J, He Z, Deng Y, Nallagatla V, Hamidi R, Flagg A, Shah N. Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease. Blood Advances 2024, 8: 1908-1919. PMID: 38324722, PMCID: PMC11021890, DOI: 10.1182/bloodadvances.2023010749.Peer-Reviewed Original ResearchCitationsAltmetric
2023
Mediport use as an acceptable standard for CAR T cell infusion
Eylon M, Prabhu S, John S, King M, Bhatt D, Curran K, Erickson C, Karras N, Phillips C, Satwani P, Hermiston M, Southworth E, Baumeister S, Talano J, MacMillan M, Rossoff J, Bonifant C, Myers G, Rouce R, Toner K, Driscoll T, Katsanis E, Salzberg D, Schiff D, De Oliveira S, Capitini C, Pacenta H, Pfeiffer T, Shah N, Huynh V, Skiles J, Fraint E, McNerney K, Quigg T, Krueger J, Ligon J, Fabrizio V, Baggott C, Laetsch T, Schultz L. Mediport use as an acceptable standard for CAR T cell infusion. Frontiers In Immunology 2023, 14: 1239132. PMID: 37965315, PMCID: PMC10642031, DOI: 10.3389/fimmu.2023.1239132.Peer-Reviewed Original ResearchCitationsAltmetricMixed donor chimerism following stem cell transplantation for sickle cell disease
Shah N, Rangarajan H, Ngwube A, Shenoy S. Mixed donor chimerism following stem cell transplantation for sickle cell disease. Current Opinion In Hematology 2023, 30: 187-193. PMID: 37694765, DOI: 10.1097/moh.0000000000000786.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricCan defibrotide prophylaxis prevent sinusoidal obstruction syndrome following haematopoietic stem-cell transplantation?
Shah N, Shenoy S. Can defibrotide prophylaxis prevent sinusoidal obstruction syndrome following haematopoietic stem-cell transplantation? The Lancet Haematology 2023, 10: e309-e311. PMID: 37001535, DOI: 10.1016/s2352-3026(23)00065-0.Peer-Reviewed Original ResearchCitationsAltmetricRole of abatacept in the prevention of graft-versus-host disease: current perspectives
Ngwube A, Rangarajan H, Shah N. Role of abatacept in the prevention of graft-versus-host disease: current perspectives. Therapeutic Advances In Hematology 2023, 14: 20406207231152644. PMID: 36845849, PMCID: PMC9943961, DOI: 10.1177/20406207231152644.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
News
Copy Link
News
- July 26, 2023
2022-23 Department of Pediatrics Faculty Awards
- May 04, 2023
42 Yale Pediatricians Recognized by Connecticut Magazine's 2023 “Top Doctors” List
- May 01, 2023
Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians
- October 12, 2022
Pediatric Bone Marrow Transplant Reunion
Get In Touch
Copy Link
Contacts
Email